AIRS AirSculpt Technologies, Inc.
USHealthcareAs of 2026-07-09 12:53
Why AIRS matters now
AirSculpt Technologies, Inc. (AIRS) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.39 with +5.02% on the session and $309.7M in market capitalization; recent performance reads 1-month +1.65% and YTD +149.50%.
The latest financial table shown here is Q1 2026, with revenue of $39.4M, net income of $-2.4M, and EPS of $-0.03. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 2.0%.
The latest indexable market news headline is "AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions" from Business Wire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $4.50; recent insider activity includes Feinstein Adam T filing J-Other. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
3.42
P/S
2.30
EV/EBITDA
93.18
DCF Value
$-0.89
FCF Yield
2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.6%
Operating Margin
-7.5%
Net Margin
-7.4%
ROE
-12.4%
ROA
-5.8%
ROIC
-5.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $39.4M | $-2.4M | $-0.03 |
| Q4 2025 | $33.4M | $1.3M | $0.02 |
| FY 2025 | $151.8M | $-11.7M | $-0.19 |
| Q3 2025 | $35.0M | $-9.5M | $-0.15 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$4.50
Target (Median)
$4.50
Target Range
$4.50 - $4.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
2.34
AirSculpt Technologies, Inc. operates as a holding company, overseeing its subsidiaries, including EBS Intermediate Parent LLC, which specializes in providing body contouring services throughout the United States. The company's flagship offering is its unique AirSculpt procedure, a minimally invasive method for custom body sculpting through the precise removal of unwanted fat. Beyond targeted fat reduction, AirSculpt also performs fat transfer procedures, utilizing a patient's own adipose cells to naturally augment areas such as the breasts, buttocks, or hips. Notable specialized treatments include the Power BBL, a Brazilian butt lift; the Up a Cup for breast enhancement; and the Hip Flip, designed to achieve an hourglass silhouette. As of March 10, 2022, AirSculpt maintained a network of 19 operational centers across 15 U.S. states. Established in 2012, AirSculpt Technologies, Inc. has its corporate headquarters situated in Miami Beach, Florida.